Reviva Pharmaceuticals Holdings Stock Market Value
| RVPHW Stock | USD 0.13 0.02 13.33% |
| Symbol | Reviva |
Reviva Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (2.34) | Return On Equity (17.95) |
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reviva Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Reviva Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Reviva Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Reviva Pharmaceuticals.
| 10/30/2023 |
| 10/24/2024 |
If you would invest 0.00 in Reviva Pharmaceuticals on October 30, 2023 and sell it all today you would earn a total of 0.00 from holding Reviva Pharmaceuticals Holdings or generate 0.0% return on investment in Reviva Pharmaceuticals over 360 days. Reviva Pharmaceuticals is related to or competes with Reviva Pharmaceuticals. Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medi... More
Reviva Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Reviva Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Reviva Pharmaceuticals Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 22.81 | |||
| Information Ratio | 0.0506 | |||
| Maximum Drawdown | 129.53 | |||
| Value At Risk | (33.33) | |||
| Potential Upside | 30.0 |
Reviva Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Reviva Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Reviva Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Reviva Pharmaceuticals historical prices to predict the future Reviva Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0529 | |||
| Jensen Alpha | 1.08 | |||
| Total Risk Alpha | (0.78) | |||
| Sortino Ratio | 0.0472 | |||
| Treynor Ratio | 1.27 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Reviva Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Reviva Pharmaceuticals Backtested Returns
Reviva Pharmaceuticals is out of control given 3 months investment horizon. Reviva Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.12, which implies the firm had a 0.12% return per unit of risk over the last 3 months. We have analyze and collected data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 15.18% are justified by taking the suggested risk. Use Reviva Pharmaceuticals Coefficient Of Variation of 1836.6, semi deviation of 18.34, and Risk Adjusted Performance of 0.0529 to evaluate company specific risk that cannot be diversified away. Reviva Pharmaceuticals holds a performance score of 9 on a scale of zero to a hundred. The company holds a Beta of 0.9, which implies possible diversification benefits within a given portfolio. Reviva Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Reviva Pharmaceuticals is expected to follow. Use Reviva Pharmaceuticals treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day median price , to analyze future returns on Reviva Pharmaceuticals.
Auto-correlation | 0.58 |
Modest predictability
Reviva Pharmaceuticals Holdings has modest predictability. Overlapping area represents the amount of predictability between Reviva Pharmaceuticals time series from 30th of October 2023 to 27th of April 2024 and 27th of April 2024 to 24th of October 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Reviva Pharmaceuticals price movement. The serial correlation of 0.58 indicates that roughly 58.0% of current Reviva Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.58 | |
| Spearman Rank Test | 0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Reviva Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Reviva Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Reviva Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Reviva Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Reviva Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Reviva Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Reviva Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Reviva Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Reviva Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Reviva Pharmaceuticals Lagged Returns
When evaluating Reviva Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Reviva Pharmaceuticals stock have on its future price. Reviva Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Reviva Pharmaceuticals autocorrelation shows the relationship between Reviva Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Reviva Pharmaceuticals Holdings.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| V | Visa Class A | |
| MSFT | Microsoft |
Additional Tools for Reviva Stock Analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.